{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06339203",
            "orgStudyIdInfo": {
                "id": "5240002"
            },
            "organization": {
                "fullName": "Loma Linda University",
                "class": "OTHER"
            },
            "briefTitle": "Intraoperative Wound Irrigation in Cesarean Section",
            "officialTitle": "Intraoperative Wound Irrigation in Cesarean Section: A Randomized Control Trial",
            "therapeuticArea": [
                "Infectious Diseases",
                "Other"
            ],
            "study": "intraoperative-wound-irrigation-in-cesarean-section"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-25",
            "studyFirstSubmitQcDate": "2024-03-25",
            "studyFirstPostDateStruct": {
                "date": "2024-04-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Ruofan Yao",
                "investigatorTitle": "Associate Professor of Gynecology and Obstetrics, Maternal Fetal Medicine Section Chief",
                "investigatorAffiliation": "Loma Linda University"
            },
            "leadSponsor": {
                "name": "Loma Linda University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Irrimax Corporation",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile water for irrigation. The study aims to evaluate the impact on postoperative wound healing in patients who have undergone cesarean delivery."
        },
        "conditionsModule": {
            "conditions": [
                "Cesarean Section Complications",
                "Cesarean Section; Infection"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 400,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Irrisept",
                    "type": "EXPERIMENTAL",
                    "description": "The experimental arm will receive irrigation solution Irrisept administered through a proprietary bottle (jet lavage) following the closure of the fascia in Cesarean section.",
                    "interventionNames": [
                        "Device: Irrisept"
                    ]
                },
                {
                    "label": "Normal Saline",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "The active comparator arm will receive the standard of care irrigation solution, normal saline, administered via standard pour over following the closure of the fascia in Cesarean section.",
                    "interventionNames": [
                        "Drug: Normal Saline"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Irrisept",
                    "description": "450ml low concentration (0.05%) Chlorhexidine Gluconate (CHG) in 99.95% Sterile Water",
                    "armGroupLabels": [
                        "Irrisept"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Normal Saline",
                    "description": "450mL",
                    "armGroupLabels": [
                        "Normal Saline"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Composite wound evaluation after caesarean delivery",
                    "description": "Redness, bruising, discharge, tissue breakdown",
                    "timeFrame": "Up to 8 weeks postop"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 18 or older\n* Singleton pregnancy\n* Planned cesarean delivery at gestational age 37 weeks or later at Loma Linda University Children's Hospital\n* Planned post-operative follow up with Loma Linda OBGYN\n* Speak English or Spanish\n* At least one of the following medical complications: Obesity BMI\\>= 30kg/m2, Diabetes, Spontaneous rupture of membranes, Intraamniotic infection\n\nExclusion Criteria:\n\n* Emergency cesarean delivery",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Nikia Gray-Hutto, AS",
                    "role": "CONTACT",
                    "phone": "9095584000",
                    "phoneExt": "44428",
                    "email": "nhutto@llu.edu"
                },
                {
                    "name": "Ashra Denise Tugung, BS",
                    "role": "CONTACT",
                    "phone": "9096515580",
                    "email": "atugung@llu.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ruofan Yao, MD, MPH",
                    "affiliation": "Loma Linda University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Loma Linda University",
                    "city": "Loma Linda",
                    "state": "California",
                    "zip": "92354",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nikia Gray Hutto, AS",
                            "role": "CONTACT",
                            "phone": "909-558-4000",
                            "phoneExt": "44428",
                            "email": "nhutto@llu.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.04835,
                        "lon": -117.26115
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M5953",
                    "name": "Chlorhexidine",
                    "relevance": "LOW"
                },
                {
                    "id": "M344731",
                    "name": "Chlorhexidine gluconate",
                    "relevance": "LOW"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                }
            ]
        }
    },
    "hasResults": false
}